Amarin Corp Plc (AMRN)

[MedResCollab]

Many research papers highlight only the downside or detraction to a position, especially in response to overly-positive papers that promulgate an idea. Our report specifically set out to see what detractions there could be in the REDUCE-IT data, to counter-balance the absolute flood of positive writing on the trial, and because the scientific method demands it.

Do not forget, a clinical trial is designed to prove a hypothesis wrong, not right.

https://blogs.stjude.org/progress/hypothesis-must-be-falsifiable/

We seriously doubt many AMRN bulls have read much of our citizen petition, much in the same way a certain poster here, despite his great expertise in patent law, has not even examined the Vascepa IP. It is a form of denial. The inability to truly and exhaustively seek to refute something you believe, something you very much want to be true.

Kind Regards,
-MRC